$87.68 Million in Sales Expected for Exponent, Inc. (EXPO) This Quarter

Analysts expect Exponent, Inc. (NASDAQ:EXPO) to report $87.68 million in sales for the current quarter, Zacks Investment Research reports. Two analysts have provided estimates for Exponent’s earnings, with the highest sales estimate coming in at $88.30 million and the lowest estimate coming in at $87.05 million. Exponent posted sales of $80.47 million in the same quarter last year, which would indicate a positive year-over-year growth rate of 9%. The company is expected to report its next quarterly earnings results on Wednesday, April 18th.

On average, analysts expect that Exponent will report full year sales of $87.68 million for the current year, with estimates ranging from $346.80 million to $356.38 million. For the next financial year, analysts anticipate that the company will report sales of $384.79 million per share. Zacks’ sales averages are a mean average based on a survey of sell-side analysts that follow Exponent.

Exponent (NASDAQ:EXPO) last issued its earnings results on Thursday, February 1st. The business services provider reported $0.47 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.42 by $0.05. Exponent had a net margin of 11.88% and a return on equity of 17.81%. The firm had revenue of $82.72 million during the quarter, compared to the consensus estimate of $80.27 million. During the same quarter in the prior year, the firm earned $0.39 earnings per share. The business’s quarterly revenue was up 13.7% on a year-over-year basis.

EXPO has been the subject of several recent analyst reports. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $82.00 target price on shares of Exponent in a research note on Sunday, November 5th. BidaskClub downgraded shares of Exponent from a “buy” rating to a “hold” rating in a research note on Saturday, December 9th. Zacks Investment Research downgraded shares of Exponent from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, December 19th. Finally, SunTrust Banks raised shares of Exponent from a “hold” rating to a “buy” rating and set a $84.00 target price for the company in a research note on Friday, January 26th. Two investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. The stock has an average rating of “Buy” and an average price target of $82.67.

Several hedge funds have recently modified their holdings of the company. Public Employees Retirement System of Ohio increased its position in shares of Exponent by 0.4% during the second quarter. Public Employees Retirement System of Ohio now owns 63,306 shares of the business services provider’s stock worth $3,691,000 after acquiring an additional 256 shares in the last quarter. Advisor Group Inc. increased its position in shares of Exponent by 15.4% during the second quarter. Advisor Group Inc. now owns 2,131 shares of the business services provider’s stock worth $124,000 after acquiring an additional 284 shares in the last quarter. The Manufacturers Life Insurance Company increased its position in shares of Exponent by 2.2% during the second quarter. The Manufacturers Life Insurance Company now owns 20,448 shares of the business services provider’s stock worth $1,192,000 after acquiring an additional 434 shares in the last quarter. US Bancorp DE increased its position in shares of Exponent by 10.8% during the fourth quarter. US Bancorp DE now owns 7,979 shares of the business services provider’s stock worth $567,000 after acquiring an additional 779 shares in the last quarter. Finally, TD Asset Management Inc. increased its position in shares of Exponent by 6.1% during the third quarter. TD Asset Management Inc. now owns 13,900 shares of the business services provider’s stock worth $1,027,000 after acquiring an additional 800 shares in the last quarter. 91.42% of the stock is owned by institutional investors.

Shares of Exponent (NASDAQ EXPO) traded up $0.75 during trading hours on Monday, reaching $76.25. 78,400 shares of the company’s stock traded hands, compared to its average volume of 93,500. Exponent has a 1 year low of $56.95 and a 1 year high of $78.39. The company has a market capitalization of $1,948.71, a P/E ratio of 39.53 and a beta of 0.72.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 23rd. Stockholders of record on Friday, March 2nd will be given a dividend of $0.26 per share. This is an increase from Exponent’s previous quarterly dividend of $0.21. The ex-dividend date of this dividend is Thursday, March 1st. This represents a $1.04 annualized dividend and a dividend yield of 1.36%. Exponent’s dividend payout ratio is currently 55.26%.

ILLEGAL ACTIVITY NOTICE: This story was originally published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this story on another publication, it was illegally copied and reposted in violation of U.S. and international copyright & trademark law. The legal version of this story can be viewed at https://www.dispatchtribunal.com/2018/02/22/87-68-million-in-sales-expected-for-exponent-inc-expo-this-quarter.html.

Exponent Company Profile

Exponent, Inc (Exponent), along with its subsidiaries, is a science and engineering consulting company. Exponent provides engineering and scientific consulting services to clients around the world. Its service offerings are provided on a project-by-project basis. It operates in two segments: Engineering and Other Scientific, and Environmental and Health.

Get a free copy of the Zacks research report on Exponent (EXPO)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply